Melanoma susceptibility and cell cycle genes in Xiphophorus hybrids

Molecular Carcinogenesis

Volumn 46, Issue 8, 2007, Pages 685-691

  Butler, Andrew P ^a   Trono, David ^a   Beard, Rebecca ^a   Fraijo, Rachel ^a   Naim, Rodney S ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Animal model; CDKN2 genes; Genetic hybridization; Skin cancer

Indexed keywords

CYCLIN DEPENDENT KINASE; MESSENGER RNA; PROTEIN P15; PROTEIN P16;

BACKCROSSING; CANCER MODEL; CANCER SUSCEPTIBILITY; CDKN2AB GENE; CELL CYCLE; CELL CYCLE G1 PHASE; CONFERENCE PAPER; FISH; GENE OVEREXPRESSION; GENETIC SUSCEPTIBILITY; HOMOZYGOSITY; HUMAN; HYBRID; MELANOMA; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; XIPHOPHORUS; XIPHOPHORUS HELLERI; XIPHOPHORUS MACULATUS;

ANIMALS; CYPRINODONTIFORMES; DISEASE SUSCEPTIBILITY; GENES, CDC; MELANOMA, EXPERIMENTAL; SKIN NEOPLASMS;

ANIMALIA; MAMMALIA; XIPHOPHORUS; XIPHOPHORUS MACULATUS;

EID: 34547900311     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20343     Document Type: Conference Paper

References (55)

1. Humm DG, Young RS. The embryological origin of pigment cells in platyfish-swordtail hybrids. Zoologica 1956;41:1-10.
2. Atz JW. Effects of hybridization on pigmentation in fishes of the genus Xiphophorus. Zoologica 1962;47:153-181.
3. Kallman KD. Different genetic basis of identical pigment patterns in two populations of platyfish, Xiphophorus maculatus. Copeia 1970;3:472-487.
4. Gordon M. The genetics of a viviarous top-minnow Platypoecilus; the inheritance of two kinds of melanophores. Genetics 1927;12:253-283.
5. Kosswig C. Uber bastarde der teleostier Platypoecilus und Xiphophorus. Z indukt Abstammungs 1927;44:253-257.
6. Haussler G. Uber melanobuildung bei bastarden von Xiphophorus helleri and Platypoecilus maculatus var. rubra. Klin Wochenschrift 1928;7:1561-1562.
7. Grand CG, Gordon M, Cameron G. Neoplasm studies, VIII: Cell types in tissue culture of fish melanotic tumors compared with mammalian melanomas. Cancer Res 1941;1:660-666.
8. Riehl R, Schartl M, Kollinger G. Comparative studies on the ultrastructure of malignant melanoma in fish and humans by freeze-etching and transmission electron microscopy. J Cancer Res Clin Oncol 1984;107:21-31.
9. Gordon M. Hereditary basis of melanosis in hybrid fishes. Am J Cancer 1931;30:362-375.
10. Breider H. Uber melanosarkome, melaninbildung und hologoge zellmechanismen. Strahlentherapie 1952;88:619-639.
11. Vielkind JR, Kallman KD, Morizot DC. Genetics of melanomas in Xiphophorus fishes. J Aquat Anim Health 1989;1:69-77.
12. Anders F. Contributions of the Gordon-Kosswig melanoma system to the present concept of neoplasia. Pigment Cell Res 1991;4:7-29.
13. Meierjohann S, Schartl M. From Mendelian to molecular genetics: the Xiphophorus melanoma model. Trends Genet 2006;490:654-661.
14. Siciliano MJ, Morizot DC, Wright DA. Factors responsible for platyfish-swordtail hybrid melanoms - Many or few? Pigm Cell 1976;2:47-58.
15. Morizot DC, Siciliano MJ. Linkage group V of platyfishes and Swordtails of the genus Xiphophorus (Poeciliidae): Linkage of loci for malate dehydrogenase-2 and esterase-1 and esterase-4 with a gene controlling the severity of hybrid melanomas. J Natl Cancer Inst 1983;71:809-813.
16. Vielkind U. Genetic control of cell differentiation in platyfish-swordtail melanomas. J Exp Zool 1976;196:197-204.
17. Schartl M. Platyfish and swordtails: A genetic system for the analysis of molecular mechanisms in tumor formation. Trends Genet 1995;11:185-189.
18. Zechel C, Peters H, Schleenbecker U, Anders F. Expression of genes related to the human erbB, erbA, pdgf and pdgf-r in tumors of different etiology in Xiphophorus. Int J Cancer 1992;52:66-75.
19. Wittbrodt J, Lammers R, Malitschek B, Ullrich A, Schartl M. The Xmrk receptor tyrosine kinase is activated in Xiphophorus malignant melanoma. EMBO J 1992;11:4239-4246.
20. Meierjohann S, Schartl M, Volff J-N. Genetic biochemical and evolutionary facets of Xmrk-induced melanoma formation in the fish Xiphophorus. Comp Biochem Physiol C Toxicol Pharmacol 2004;138:281-289.
21. Nairn RS, Kazianis S, McEntire BB, Della Coletta L, Walter RB, Morizot DC. A CDKN2-like polymorphism in Xiphophorus LG V is associated with UV-B-induced melanoma formation in platyfish-swordtail hybrids. Proc Natl Acad Sci USA 1996;93:13042-13047.
22. Nairn RS, Morizot DC, Kazianis S, Woodhead AD, Setlow RB. Nonmammalian models for sunlight carcinogenesis: Genetic analysis of melanoma formation in Xiphophorus hybrid fish. Photochem Photobiol 1996;64:440-448.
23. Kazianis S, Gutbrod H, Nairn RS, et al. Localization of a CDKN2 gene in linkage group V of Xiphophorus fishes defines it as a candidate for the DIFF tumor suppressor. Genes, Chromosomes Cancer 1998;22:210-220.
24. Nairn RS, Kazianis S, Della Coletta L, et al. Genetic analysis of susceptibility to spontaneous and UV carcinogenesis in Xiphophorus hybrid fish. Marine Biotech 2001;3:S24-S36.
25. Setlow RB, Woodhead AD, Grist E. Animal model for ultraviolet radiation-induced melanoma: Platyfish-swordtail hybrid. Proc Natl Acad Sci USA 1989;86:8922-8926.
26. Weiss S, Schartl M. The macromelanophore locus and the melanoma oncogene Xmrk are separate genetic entities in the genome of Xiphophorus. Genetics 1998;149:1909-1920.
27. Kazianis S, Nairn RS, Walter RB, et al. The genetic map of Xiphophorus fishes represented by 24 multipoint linkage groups. Zebrafish 2004;1:287-304.
28. Kazianis S, Morizot DC, Della Coletta L, et al. Comparative structure and characterization of a CDKN2 gene in a Xiphophorus fish melanoma model. Oncogene 1999;18:5088-5099.
29. Baudler M, Schartl M, Altschmied J. Specific activation of a STAT family member in Xiphophorus melanoma cells. Experiment Cell Res 1999;249:212-220.
30. Morcinek JC, Weisser C, Geissinger E, Schartl M, Wellbrock C. Activation of STAT5 triggers proliferation and contributes to anti-apoptotic signalling mediated by the oncogenic Xmrk kinase. Oncogene 2002;21:1668-1678.
31. Wellbrock C, Schartl M. Activation of phosphatidylinositol 3-kinase by a complex of p59fyn and the receptor tyrosine kinase Xmrk is involved in malignant transformation of pigment cells. Eur J Biochem 2000;267:3513-3522.
32. Rudd MD, Johnston DA, Kazianis S, Butler AP. Cloning and analysis of a FoxO transcription factor from Xiphophorus Gene 2003;302:31-41.
33. Wellbrock C, Schartl M. Multiple binding sites in the growth factor receptor Xmrk mediate binding to p59fyn, GRB2 and Shc. European J Biochem 1999;260:275-283.
34. Delfgaauw J, Duschl J, Wellbrock C, Froschauer C, Schartl M, Altschmied J. MITF-M plays an essential role in transcriptional activation and signal transduction in Xiphophorus melanoma. Gene 2003;320:117-126.
35. Ruas M, Peters G. The p16INK4a/CDKN2A tumor suppressor and its relatives. Biochim Biophys Acta 1999;1378:F115-F177.
36. Ortega S, Malumbres M, Barbacid M. Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim Biophys Acta 2002;1602:73-87.
37. Chin L, Merlino G, DePinho RA. Malignant melanoma: Modern black plague and genetic black box. Genes Dev 1998;12:3467-3481.
38. Hayward NK. Genetics of melanoma predisposition. Oncogene 2003;22:3053-3062.
39. Gonzalez-Zulueta M, Bender CM, Yang AS, et al. Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res 1995;55:4531-4535.
40. Herman JG, Merlo A, Mao L, et al. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 1995;55:4525-4530.
41. Gilley J, Fried M. One INK4 gene and no ARF at the Fugu equivalent of the human INK4A/ARF/INK4B tumour suppressor locus. Oncogene 2001;20:7447-7452.
42. Kazianis S, Khanolkar VA, Nairn RS, et al. Structural organization, characterization and evolutionary relationships of CDKN2 gene family members in Xiphophorus fishes. Comp Biochem Physiol C Toxicol Pharmacol 2004;138:291-299.
43. Kazianis S, Della Coletta L, Morizot DC, Johnston DA, Osterndorff EA, Nairn RS. Overexpression of a fish CDKN2 gene in a hereditary melanoma model. Carcinogenesis 2000;21:599-605.
44. Butler AP, Trono D, Della Coletta L, et al. Regulation of CDKN2A/B and Retinoblastoma genes in Xiphophorus melanoma. Comp Biochem Physiol C Toxicol Pharmacol 2007;145:145-155.
45. Satyamoorthy K, Li G, Gerrero MR, et al. Constitutive mitogen-activated protein kinase activation in melanoma is mediated by both BRAF mutations and autocrine growth factor stimulation. Cancer Res 2003;63:756-759.
46. Davies H, Bignell GR, Cox C, et al. Mutations of the BRAF gene in human cancer. Nature 2002;417:949-954.
47. Chin L. The genetics of malignant melanoma: Lessons from mouse and man. Nat Rev Cancer 2003;3:559-570.
48. Sharpless NE. Ink4a/ARF: A multifunctional tumor suppressor locus. Mutation Res 2005;576:22-38.
49. Emig R, Magener A, Ehemann V, et al. Aberrant cytoplasmic expression of the p16 protein in breast cancer is associated with accelerated tumour proliferation. Br J Cancer 1998;78:1661-1668.
50. Sano T, Oyama T, Kashiwabara K, Fukuda T, Nakajima T. Immunohistochemical overexpression of p16 protein associated with intact retinoblastoma protein expression in cervical cancer and cervical intraepithelial neoplasia. Pathol Int 1998;48:580-585.
51. Shigemasa K, Hu C, West CM, et al. p16 overexpression: A potential early indicator of transformation in ovarian carcinoma. J Soc Gynecol Investig 1997;4:95-102.
52. Asamoto M, Hori T, Baba-Toriyama H, et al. p16 gene overexpression in mouse bladder carcinomas. Cancer Lett 1998;127:9-13.
53. Fang X, Jin X, Xu H-J, et al. Expression of p16 induces transcriptional downregulation of the RB gene. Oncogene 1998;16:1-8.
54. Otterson G, Kratzke R, Coxon A, Kim YW, Kaye FJ. Absence of p16INK4 protein is restricted to the subset of lung cancer lines that retains wildtype RB. Oncogene 1994;11:3375-3378.
55. Kim WY, Sharpless NE. The regulation of Ink4/ARF in cancer and aging. Cell 2006;127:265-275.